[Tinnitus in the diagnosis and prognosis of ototoxicity].
The prognostic value of tinnitus about the occurrence of hypoacusia in a patient undergoing an ototoxic treatment is not know. Ninety-five patients treated with cisplatinum, a cocleotoxic drug, have been studied to evaluate the percentage of patients with tinnitus, to assess the characteristics of these tinnitus and to know if there is a relationship between its occurrence and the degree of hearing loss that appears after treatment. Thirty-six patients (37.9%) had tinnitus, and there was not a statistically significant relationship between this symptom and the hearing loss. Therefore, tinnitus cannot be used as a prognostic factor for hypoacusia in patients undergoing treatment with cisplatinum.
Doménech
J
J
Cátedra de ORL, Facultad de Medicina, Universidad de Barcelona.
Carulla
M
M
Traserra
J
J
D002945:Cisplatin / Q000009:adverse effects*; D034381:Hearing Loss / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D006801:Humans; D011379:Prognosis; D014012:Tinnitus / Q000139:chemically induced* / Q000209:etiology
D002945:Cisplatin
Los acúfenos en el diagnóstico y pronóstico de la ototoxicidad.